Health & Medicine

Plenary Lecture

Innovative Medicines

11:00-11:10 Chair/Introduction Dr. Jorgen Dirach, Chairman EFB Section on Medicines Development EFB Section on Medicines Development; Director, Novo Nordisk, Denmark

11:10-11:30Innovative Medicines Initiative Strategic Research Agenda-an overview.Dr. Jorgen Dirach, Chairman EFB Section on Medicines Development EFB Section on Medicines Development; Director, Novo Nordisk, Denmark

11:35-12:00Roadmap to treatment: The role of patient organisations in research & medicines development.Dr. Alastair Kent, Director Genetic Interest Group; President European Genetic alliances Network, UK

12:00-12:20Regulation of medicines development and market authorisation: How can the regulatory authorities help the process?Dr. Outi Maki-Ikola, Senior Scientific Administrator, Pre-Authorisation Human Unit/ Safety and Efficacy Sector, European Medicines Agency (EMEA), UK

12:25-12:50The Innovative Medicines Initiative (IMI) a novel approach to stimulate and fund European ResearchDr. Philippe Cupers, Scientific officer, Unit Major Diseases – Directorate Health Research, DG Research, European Commission

12:50-13:00Discussion & Conclusions 

Antibody-based therapeutics

15:00-15:10Chair/IntroductionSir. Greg Winter, Acting Director, MRC Laboratory of Molecular Biology, UK

15:10-15:35Antibody-based vascular targeting: from the bench to the clinicProf. Dr. Dario Neri, Professor, Swiss Federal Institute of Technology Zurich, Switzerland

15:35-16:00Antibody Therapeutics: Innovation through target discovery and novel molecular designDr. Neil Weir, Senior VP, UCB Group, UK

16:00-16:25Detection of cancer using affinity proteomics based on antibody microarraysProf. Carl Borrebaeck, Professor & Chair, Department of Immunotechnology, Lund University, Sweden

16:25-16:50High titre, stable mammalian cell lines using novel characterized synthetic genetic elementsDr. Raymond Jacquet, Head of cell culture, Selexis SA, Switzerland

16:50-17:00Discussion & Conclusions

Plenary Lecture

Plenary Lecture

Systems Biology & Biosimulation

11:00-11:10Chair/IntroductionProf. Lilia Alberghina, Professor, Dept. of Biotechnology and Biosciences, University of Milano-Bicocca, Italy

11:10-11:35Yeast systems biology as a foundation for drug discovery and preventive medicineProf. Stefan Hohmann, Professor, Dept. of Cell & Molecular Biology/Microbiology, Göteborg University, Sweden

11:35-12:00Dynamic pathway modeling and cancerDr. Andrea Pfeifer, Postdoctoral Fellow, Systems Biology of Signal Transduction, German Cancer Research Center (DKFZ), Germany

12:00-12:25From Data Integration to Systems Modeling: Disease Pathway Reconstruction, Drug Target Validation and Integrated Efficacy and Toxicity StudiesDr. Hans Peter Fischer, Chief Scientific Officer, Genedata AG, Switzerland

12:25-12:50In Silico Model of the Mitochondrial Role in Cardiac Cell undergoing Angina PectorisProf. Manuel Canovas, University of Murcia, Spain

14:50-15:00Discussion & Conclusions 

Biomarkers including diagnostics & imaging

15:00-15:10Chair/IntroductionAlberico Catapano, University of Milano, Italy / Andreani Odysseos, Director of Biomedical Research,EPOS-Iasis, R&D; Special Scientist, University of Cyprus

15:10-15:35The Role of Novel Biomarkers in Drug DevelopmentDr. Thomas Metcalfe, Head of Biomarker Program, F. Hoffmann-La Roche Ltd, Switzerland

15:35-16:00Experimental Molecular Imaging of CancerProf. Bertrand Tavitian, Head, Laboratory for Experimental Molecular Imaging, CEA, France

16:00-16:20Optical Molecular Imaging in novel diagnostics and therapeuticsDr. Constantinos Pitris, Professor, Department of Electrical and Computer Engineering, University of Cyprus

16:20-16:50Molecular imaging approaches in the diagnosis and treatment monitoring of vascular atheromatosisDr. Vito Lorusso, Imaging Technology Head at Bracco Research Centre, Bracco Imaging S.p.A., Italy

16:50-17:00Discussion & Conclusions 

Plenary Lecture

Plenary Lecture

Advanced Drug/Gene Delivery Systems

11:00-11:10Chair/IntroductionProf. Turkan Eldem, Vice-Chair EFB section on Medicines Development, Pharmaceutical Biotechnology Department, Hacettepe University, Turkey

11:10-11:30Carbon nanotubes for the delivery of therapeutic moleculesDr. Kostas Kostarelos, Professor & Deputy Head, Centre for Drug Delivery Research, School of Pharmacy, University of London, United Kingdom

11:35-12:00Delivery of siRNA in vivo: strategies for local and systemic administrationDr. Raymond Schiffelers, Assistant Professor, Department of Pharmaceutics, Utrecht University, The Netherlands

12:25-12:50Time-resolved gene expression experiments by using a single-cell electroporation microarrayDr. Lisbet Santoni, Narvalus s.r.l., Italy

12:50-13:00Discussion & Conclusions 

Nanobiotechnology in Medicine

15:00-15:10Chair/IntroductionProf. Josep Samitier, Director, NanoBioengineering Laboratory, Institute for Bioengineering of Catalonia, University of Barcelona, Spain

15:10-15:30Industrialisation of NanomedicinesProf. Mike Eaton, Head of Biological Chemistry, UCB group, UK

15:35-16:00Nanotechnological strategies for regenerative medicine in vitro approachesProf. James Kirkpatrick, President of European Society for Biomaterials; Professor & Director, Institute of Pathology, Johannes Gutenberg University, Germany

16:00-16:20Contrast agents and molecular imagingDr. Dirk Burdinski, Bio-Molecular Engineering, Philips Research Laboratories, The Netherlands

16:50-17:00Discussion & Conclusions

Plenary Lecture